Discover 1,444 paid clinical trials in Akron, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,444
Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System
for
Focal Segmental Glomerulosclerosis
Location: Akron OH, Grand Rapids MI, Wilmington DE, Richmond VA,
Sponsor: Kaneka Medical America LLC
Sex: All
Age: 0 - 70+
Code: NCT04065438
Recruiting
International Rare Brain Tumor Registry
for
Astroblastoma, BCOR ITD Sarcoma, CNS Sarcoma,
Location: Akron OH, Cincinnati OH, Washington D.C. DC, Chicago IL,
Sponsor: Children's National Research Institute
Sex: All
Age: 0 - 45
Code: NCT05697874
Recruiting
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
for
Focal Segmental Glomerulosclerosis
Location: Akron OH, Grand Rapids MI, Wilmington DE,
Sponsor: Kaneka Medical America LLC
Sex: All
Age: 0 - 21
Code: NCT02235857
Recruiting
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)